Hara H, Virmani R, Ladich E et al (2005) Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 46:1768–1776. https://doi.org/10.1016/j.jacc.2005.08.038
Koutroulou I, Tsivgoulis G, Tsalikakis D et al (2020) Epidemiology of patent foramen ovale in general population and in stroke patients: a narrative review. Front Neurol 11:281. https://doi.org/10.3389/fneur.2020.00281
Article PubMed PubMed Central Google Scholar
Koutroulou I, Tsivgoulis G, Karacostas D, et al (2020) Prevalence of patent foramen ovale in the Greek population is high and impacts on the interpretation of the risk of paradoxical embolism (RoPE) score. Ther Adv Neurol Disord 13. https://doi.org/10.1177/1756286420964673
Zhou G, Liu A, Zhang Y, Liu D (2024) Study on the correlation between patent foramen ovale and migraine based on meta analysis. Altern Ther Health Med AT10801
Schwedt T, Demaerschalk B, Dodick D (2008) Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 28:531–540. https://doi.org/10.1111/j.1468-2982.2008.01554.x
Article PubMed CAS Google Scholar
Pristipino C, Germonpré P, Toni D et al (2021) European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. Eur Heart J 42:1545–1553. https://doi.org/10.1093/eurheartj/ehaa1070
Zhang B, Li D, Song A et al (2022) Characteristics of patent foramen ovale: analysis from a single center. Cardiol Res Pract 2022:1–6. https://doi.org/10.1155/2022/5430598
Cao Q, Shen Y, Hou Z et al (2022) The relationship between patent foramen ovale and unexplained dizziness: a prospective analysis in China. NDT 18:1495–1505. https://doi.org/10.2147/NDT.S367140
Li Y, Shen Y, Cao Q et al (2023) Effect of interventional therapy unexplained dizziness and relationship between dizziness handicap inventory and right-to-left shunt grading. IJGM 16:803–811. https://doi.org/10.2147/IJGM.S401046
Bernard S, Churchill TW, Namasivayam M, Bertrand PB (2021) Agitated saline contrast echocardiography in the identification of intra- and extracardiac shunts: connecting the dots. J Am Soc Echocardiogr 34:1–12. https://doi.org/10.1016/j.echo.2020.09.013
Houts CR, Wirth RJ, McGinley JS et al (2020) Content validity of HIT-6 as a measure of headache impact in people with migraine: a narrative review. Headache 60:28–39. https://doi.org/10.1111/head.13701
Hjermstad MJ, Fayers PM, Haugen DF et al (2011) Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 41:1073–1093. https://doi.org/10.1016/j.jpainsymman.2010.08.016
Van Vugt VA, De Vet HCW, Van Der Wouden JC et al (2020) The 25-item Dizziness Handicap Inventory was shortened for use in general practice by 60 percent. J Clin Epidemiol 126:56–64. https://doi.org/10.1016/j.jclinepi.2020.06.021
Zhao E, Liu W, Zhang Y et al (2017) Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: a single-center prospective study. Medicine 96:e6572. https://doi.org/10.1097/MD.0000000000006572
Article PubMed PubMed Central Google Scholar
Shi Y-J, Lv J, Han X-T, Luo G-G (2017) Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis. BMC Cardiovasc Disord 17:203. https://doi.org/10.1186/s12872-017-0644-9
Article PubMed PubMed Central Google Scholar
Wilmshurst P, Nightingale S, Walsh K, Morrison W (2000) Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. The Lancet 356:1648–1651. https://doi.org/10.1016/S0140-6736(00)03160-3
Biasco L, Infantino V, Orzan F et al (2014) Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt. J Cardiol 64:390–394. https://doi.org/10.1016/j.jjcc.2014.02.023
Xing Y, Guo Y-Z, Gao Y-S et al (2016) Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine (EASTFORM) Trial. Sci Rep 6:39081. https://doi.org/10.1038/srep39081
Article PubMed PubMed Central CAS Google Scholar
Goldsweig AM, Deng Y, Yao X, et al (2024) Approval, evidence, and “off-label” device utilization: the patent foramen ovale closure story. Circ Cardiovasc Qual Outcomes 17(1):e010200. https://doi.org/10.1161/circoutcomes.123.010200
Tobis JM, Charles A, Silberstein SD et al (2017) Percutaneous closure of patent foramen ovale in patients with migraine. J Am Coll Cardiol 70:2766–2774. https://doi.org/10.1016/j.jacc.2017.09.1105
Steinmetz JD, Seeher KM, Schiess N et al (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology 23:344–381. https://doi.org/10.1016/S1474-4422(24)00038-3
Chatterjee JH, Blume HK (2022) Migraine and mental health in pediatrics. JAMA Pediatr 176:1165. https://doi.org/10.1001/jamapediatrics.2022.3948
Falla K, Kuziek J, Mahnaz SR et al (2022) Anxiety and depressive symptoms and disorders in children and adolescents with migraine: a systematic review and meta-analysis. JAMA Pediatr 176:1176. https://doi.org/10.1001/jamapediatrics.2022.3940
Article PubMed PubMed Central Google Scholar
Szperka CL, VanderPluym JH, Oakley CB (2020) Pharmacologic acute and preventive treatment for migraine in children and adolescents. JAMA Neurol 77:388. https://doi.org/10.1001/jamaneurol.2019.4170
Article PubMed PubMed Central Google Scholar
Oskoui M, Pringsheim T, Holler-Managan Y et al (2019) Practice guideline update summary: acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 93:487–499. https://doi.org/10.1212/WNL.0000000000008095
Oskoui M, Pringsheim T, Billinghurst L et al (2019) Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Headache 59:1144–1157. https://doi.org/10.1111/head.13625
Menon SC, Grove A, McFadden M et al (2014) Clinical Practice, Resource Utilization, and Outcomes of Device Closure of Patent Foramen Ovale in Pediatrics. Pediatr Neurol 50:213–217. https://doi.org/10.1016/j.pediatrneurol.2013.11.007
Mi Z, He G, Li C et al (2023) Efficacy and safety of transesophageal ultrasound-guided patent foramen ovale closure for migraine in adolescents. Front Pediatr 11:1296825. https://doi.org/10.3389/fped.2023.1296825
Article PubMed PubMed Central Google Scholar
Cao L (2019) Characteristics and analysis of right-to-left shunt-related dizziness in patients without hypoxemia. J Int Med Res 47:2921–2928. https://doi.org/10.1177/0300060519850940
Article PubMed PubMed Central Google Scholar
Justino H (2006) The ALARA concept in pediatric cardiac catheterization: techniques and tactics for managing radiation dose. Pediatr Radiol 36:146. https://doi.org/10.1007/s00247-006-0194-2
Article PubMed PubMed Central Google Scholar
Stecker MS, Balter S, Towbin RB et al (2009) Guidelines for patient radiation dose management. J Vasc Interv Radiol 20:S263–S273. https://doi.org/10.1016/j.jvir.2009.04.037
Quinn BP, Cevallos P, Armstrong A, et al (2020) Longitudinal improvements in radiation exposure in cardiac catheterization for congenital heart disease: a prospective multicenter C3PO-QI study. Circ Cardiovasc Interv 13:e008172. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008172
Wang S, Zhu G, Liu Z, et al (2022) Only transesophageal echocardiography guided patent foramen ovale closure: a single-center experience. Front Surg 9:977959. https://doi.org/10.3389/fsurg.2022.977959
Comments (0)